SLNO (Soleno Therapeutics) Rega marang bathi mangsa ngarep

Lambang korporat lan logo Soleno (SLNO)

The forward P/E ratio for Soleno Therapeutics (SLNO) reflects valuation dynamics where the value remains at 7.20, correlating with the low predictability of current cash flows prior to commercialization. Fundamentally, the business relies on the high macro-resilience of the healthcare sector, despite its dependence on external capital. The primary potential is concentrated in the breakthrough launch of the DCCR drug for the therapy of Prader-Willi syndrome.

SLNO - Rasio prakiraan rega marang bathi Soleno Therapeutics Inc ing rentang 04.07.2022 - 30.05.2026

Rincian analitis perusahaan Soleno Therapeutics

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:SLNO soleno.life
Produk merek Soleno Therapeutics Corp

The forward P/E reflects market earnings expectations, comparing current market capitalization with projected income to determine the degree of asset overvaluation. By analyzing the forward P/E metric of Soleno Therapeutics (SLNO), an investor assesses the risks of inflated expectations, which is critical for Soleno Therapeutics (SLNO) as revenue remains volatile until the commercial launch of drugs for the treatment of genetic pathologies.

Pesaing Soleno Therapeutics (SLNO)

Prakiraan rega marang bathi ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep corcept.com CORT|RYTM - Prakiraan rega marang bathi|Akero Corp - Pangali Forward P/E|Rasio prakiraan rega marang bathi Metsera Corp|MLTX (MoonLake) - Prakiraan rega marang bathi|CRNX: Rasio kapitalisasi marang bathi mangsa ngarep|NAMS (NewAmsterdam Pharma Corp) - Pangali Forward P/E|Pangali Forward P/E Amicus Therapeutics|Pangali Forward P/E ETNB|Rega marang bathi mangsa ngarep AGIO (Agios)|Rega marang bathi mangsa ngarep structuretx.com GPCR|MiMedx Corp (MDXG) - Rasio prakiraan rega marang bathi|RZLT - Rega marang bathi mangsa ngarep|LXRX: Rega marang bathi mangsa ngarep|MBX Biosciences, Inc. (MBX) - Rega marang bathi mangsa ngarep|ALT - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep bioagelabs.com (BIOA)|Prakiraan rega marang bathi Biomea Fusion, Inc. BMEA|Rega marang bathi mangsa ngarep Quince QNCX|GUTS (Fractyl Health Inc.) - Rasio rega marang bathi sing dikarepake|VTVT: Prakiraan rega marang bathi|Pangali forward rega marang bathi agapeatpgroup.com (ATPC)|PLUR (Pluri) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep SYBX|Rega marang bathi mangsa ngarep Lipocine Corporation|matinasbiopharma.com (MTNB) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SPRB|Prakiraan rega marang bathi Galecto, Inc. GLTO|Rega marang bathi mangsa ngarep Carmell Corporation CTCX|Pangali mangsa ngarep rega marang bathi LUMO|ONVO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RDUS (Radius Recycling Inc.)